(Q38283373)

1 September 2017

0 references

1 reference

title

Overexpression of ANXA2 predicts adverse outcomes of patients with malignant tumors: a systematic review and meta-analysis (English)

1 reference

1 September 2017

1 reference

1 reference

Xinyu Liu

1

1 reference

1 September 2017

Ding Ma

2

1 reference

1 September 2017

Xiaoqian Jing

3

1 reference

1 September 2017

Bingrui Wang

4

1 reference

1 September 2017

Weiping Yang

5

1 reference

1 September 2017

Weihua Qiu

6

1 reference

1 September 2017

publication date

5 December 2014

1 reference

1 September 2017

1 reference

1 September 2017

volume

32

1 reference

1 September 2017

issue

1

1 reference

1 September 2017

page(s)

392

1 reference

Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0392-Y

SWI/SNF nucleosome remodellers and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0392-Y

Annexins: linking Ca2+ signalling to membrane dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0392-Y

Annexins--unique membrane binding proteins with diverse functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0392-Y

Annexins: from structure to function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0392-Y

Annexins in human breast cancer: Possible predictors of pathological response to neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0392-Y

Correlation of expression levels of ANXA2, PGAM1, and CALR with glioma grade and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0392-Y

Annexin II represents metastatic potential in clear-cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0392-Y

Clinical and prognostic role of annexin A2 in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0392-Y

Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0392-Y

Up-regulation of annexin A2 in cholangiocarcinoma caused by Opisthorchis viverrini and its implication as a prognostic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0392-Y

Characterisation and protein expression profiling of annexins in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0392-Y

Clinical significance of annexin A2 downregulation in oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0392-Y

Practical methods for incorporating summary time-to-event data into meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0392-Y

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0392-Y

Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0392-Y

Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0392-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0392-Y

Annexin A2 is a novel RNA-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0392-Y

The annexin A2 system and vascular homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0392-Y

Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0392-Y

Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma

21 January 2018

1 reference

12 December 2020

Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas

1 reference

12 December 2020

Coexpression of ANXA2, SOD2 and HOXA13 predicts poor prognosis of esophageal squamous cell carcinoma.

1 reference

12 December 2020

Down-regulation of annexin II in prostate cancer is associated with Gleason score, recurrence, metastasis and poor prognosis

1 reference

12 December 2020

Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma

1 reference

12 December 2020

Down-regulation of annexin A1 and A2 protein expression in intestinal-type sinonasal adenocarcinomas

1 reference

12 December 2020

Prognostic and diagnostic significance of annexin A2 in colorectal cancer

1 reference

12 December 2020

10.1007/S12032-014-0392-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

1 September 2017

1001569481

0 references

1 reference